CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model
Lisa Mayr(Comprehensive Cancer Center Vienna), Bernd Kubista(Medical University of Vienna)
Cited by 27
Related Papers
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition
|Journal of Experimental & Clinical Cancer Research|2017|38
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
|Cancer Cell|2025|36